Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with PRP in TMJ Arthrocentesis
NCT05817162Phase 4Unknown
- Sponsor
- Instituto Português da Face
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in temporomandibular joint disorders (TMD), sponsored by Instituto Português da Face. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT05817162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05817162.